Prescription

https://www.dockpharmacy.com/wp-content/uploads/2018/07/rx_button_400_clr_16607-300x300.png
RELENZA DISKHALER 5MG 51

RELENZA DISKHALER 5MG For both treatment and prophylaxis of influenza. Treatment of influenza

Treatment should begin as soon as possible, within 48 hours after onset of symptoms for adults, and within 36 hours after onset of symptoms for children.

Relenza is for administration to the respiratory tract by oral inhalation only, using the Diskhaler device provided. One blister should be utilised for each inhalation.

The recommended dose of Relenza for treatment of influenza in adults and children from the age of 5 years is two inhalations (2 x 5 mg) twice daily for five days, providing a total daily inhaled dose of 20 mg. Prevention of influenza

Post-exposure prophylaxis

The recommended dose of Relenza for prevention of influenza, following close contact with an individual, is two inhalations (2 x 5 mg) once daily for 10 days. Therapy should begin as soon as possible and within 36 hours of exposure to an infected person.

Seasonal prophylaxis

The recommended dose of Relenza for prevention of influenza during a community outbreak is 2 inhalations (2 x 5 mg) once daily for up to 28 days.

Learn More
REL66X
CompareCompare
Relestat Eye Drops – Epinastine Eye drops, 5ml1

Relestat Eye Drops – Epinastine Eye drops, 5ml Relestat Eye Drops – Your Allergy Relief Solution Are you tired of struggling with the uncomfortable symptoms associated with seasonal allergic conjunctivitis? Relestat Eye Drops offers a soothing solution that provides fast and effective relief from watery itchy red swollen eyes. Say goodbye to discomfort and hello […]

Learn More
3011558
CompareCompare
REL99X
CompareCompare
REL10M
CompareCompare
RELPAX TABS 20MG 6 Tabslets1

RELPAX TABS 20MG – is indicated in adults for the acute treatment of the headache phase of migraine attacks, with or without aura. RELPAX tablets should be taken as early as possible after the onset of migraine headache but they are also effective if taken at a later stage during a migraine attack.

RELPAX, if taken during the aura phase, has not been demonstrated to prevent migraine headache and therefore RELPAX should only be taken during the headache phase of migraine.

RELPAX tablets should not be used prophylactically.

Learn More
REL68A
CompareCompare
RELPAX TABS 40MG 6 tablets1

RELPAX TABS 40MG – RELPAX tablets should be taken as early as possible after the onset of migraine headache but they are also effective if taken at a later stage during a migraine attack.

RELPAX, if taken during the aura phase, has not been demonstrated to prevent migraine headache and therefore RELPAX should only be taken during the headache phase of migraine.

RELPAX tablets should not be used prophylactically. If headache returns within 24 hours: If the migraine headache recurs within 24 hours of an initial response, a second dose of the same strength of RELPAX has been shown to be effective in treating the recurrence. If a second dose is required, it should not be taken within 2 hours of the initial dose.

If no response is obtained: If a patient does not achieve a headache response to the first dose of RELPAX within 2 hours, a second dose should not be taken for the same attack as clinical trials have not adequately established efficacy with the second dose. Clinical trials show that patients who do not respond to the treatment of an attack are still likely to respond to the treatment of a subsequent attack.

Learn More
REL67E
CompareCompare
RELVAR ELLIPTA 184/22MCG 30 Doses1

RELVAR ELLIPTA 184/22MCG – Relvar Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older where use of a combination medicinal product (long-acting beta2-agonist and inhaled corticosteroid) is appropriate:

• patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short acting beta2-agonists.

• patients already adequately controlled on both inhaled corticosteroid and long-acting beta2-agonist.

Learn More
REL97Q
CompareCompare
RELVAR ELLIPTA 92/22MCG 30 Doses1

RELVAR ELLIPTA 92/22MCG- Relvar Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older and Relvar Ellipta is indicated for the symptomatic treatment of adults with COPD

Learn More
REL96U
CompareCompare
REM105L
CompareCompare
REM83H
CompareCompare
REM82L
CompareCompare
REM110M
CompareCompare
×

Hello!

Click one of our contacts below to chat on WhatsApp

× How can I help you?